Community-acquired Pneumonia
📧 Sign up to get email alerts when something new happens for Community-acquired Pneumonia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2015-04-22Clinical Trial Update: Impact of Statins on Cytokine Expression in Pneumonia [Phase 4]
Phase 4 clinical trial evaluating the impact of statins on cytokine expression in community-acquired pneumonia was withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-04-21Clinical Trial Update: Corticosteroid Treatment for Community-Acquired Pneumonia - The STEP Trial [Phase 3]
This document reports the completion status of the STEP Phase 3 trial evaluating corticosteroid treatment for community-acquired pneumonia. …
-
CLINICAL_TRIALS trial_result · 2015-04-06Clinical Trial Update: PK Analysis of Moxifloxacin in the Treatment of CAP
A completed trial includes pharmacokinetic analysis of moxifloxacin for treating community-acquired pneumonia, with results posted in 2015.
-
FDA label_change · 2015-03-16FDA Approved: AUGMENTIN ES-600 — Supplemental Application (USAntibiotics, LLC)
FDA approved a supplemental application for AUGMENTIN ES-600 by USAntibiotics, LLC, updating the product labeling.
-
CLINICAL_TRIALS trial_result · 2015-03-05Clinical Trial Update: Pharmacokinetics of Levofloxacin in Intensive Care Unit [Phase 4]
Phase 4 study updates the pharmacokinetics of levofloxacin in ICU patients. The trial includes individuals with community-acquired pneumonia…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2015-02-13Clinical Trial Update: Effectiveness Study of Integrative Treatment for Pediatric Community Acquired Pneumonia [NA]
This entry notes an ongoing effectiveness study of integrative treatment for pediatric community-acquired pneumonia, with current status not…
-
CLINICAL_TRIALS trial_result · 2015-01-13Clinical Trial Update: Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Community Acquired Bacterial Pneumonia (CABP) [Phase 2, Phase 3]
Completed Phase 2/3 clinical trial evaluating the safety and efficacy of ceftaroline fosamil (Teflaro) versus a comparator in pediatric pati…
-
CLINICAL_TRIALS trial_result · 2014-12-17Clinical Trial Update: Efficacy and Safety of Sequential IV/PO Moxifloxacin in Comparison to IV Levofloxacin Plus IV Ceftriaxone Followed by PO Levofloxacin, in the Treatment of Patients With Community-acquired Pneumonia [Phase 3]
A Phase 3 trial comparing sequential IV/PO moxifloxacin to IV levofloxacin plus IV ceftriaxone followed by oral levofloxacin in adults with …
-
CLINICAL_TRIALS trial_result · 2014-12-17Clinical Trial Update: Study to Proof the Clinical and Bacteriological Non-inferiority of Ampicillin/Amoxicillin Versus Moxifloxacin in Hospitalized Patients With Non-severe Community-acquired Pneumonia [Phase 4]
A Phase 4 trial comparing ampicillin/amoxicillin versus moxifloxacin in hospitalized patients with non-severe community-acquired pneumonia w…
-
CLINICAL_TRIALS trial_result · 2014-12-15Clinical Trial Update: Use Of Procalcitonin Level For Guidance of The Treatment of Suspected Community Acquired Pneumonia
This clinical trial update evaluates using procalcitonin levels to guide antibiotic treatment for suspected community-acquired pneumonia. Th…
-
CLINICAL_TRIALS trial_result · 2014-11-18Clinical Trial Update: Avelox for Treatment of Elderly Patients With Community Acquired Pneumonia [Phase 4]
Phase 4 clinical trial update for moxifloxacin (Avelox) in elderly patients with community-acquired pneumonia; the study has completed.
-
CLINICAL_TRIALS trial_result · 2014-11-04Clinical Trial Update: A Study to Assess the Efficacy and Safety of IV/PO Moxifloxacin in Subjects With Community-acquired Pneumonia [Phase 3]
Phase 3 trial evaluating IV/PO moxifloxacin for community-acquired pneumonia has completed.
-
FDA approval · 2014-09-26FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Amoxicillin and Clavulanate Potassium from Teva Pharmaceuticals USA, Inc. The supplement rel…
-
FDA label_change · 2014-09-22FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Northstar RxLLC)
The FDA approved a supplemental application for amoxicillin and clavulanate potassium filed by Northstar RxLLC, resulting in a label update …
-
CLINICAL_TRIALS trial_result · 2014-08-26Clinical Trial Update: Improving Pneumococcal Vaccination Rates in an Ambulatory Pre-surgical Testing Setting [NA]
Completed clinical trial evaluating strategies to improve pneumococcal vaccination rates in ambulatory pre-surgical testing settings.
-
CLINICAL_TRIALS research · 2014-07-29Clinical Trial Update: The Impact of Simultaneous Presence of Viral and Bacterial Pathogens on Therapy and Course of Severe Pneumonia
This clinical trial update investigates how simultaneous viral and bacterial pathogens influence therapy and outcomes in severe pneumonia.
-
CLINICAL_TRIALS trial_result · 2014-07-02Clinical Trial Update: A Safety and Tolerability Study of Doripenem Compared With Cefepime in Hospitalized Children With Bacterial Pneumonia [Phase 3]
Phase 3 safety and tolerability trial comparing doripenem to cefepime in hospitalized children with bacterial pneumonia; the study was termi…
-
CLINICAL_TRIALS trial_result · 2014-05-28Clinical Trial Update: Delayed Antibiotic Treatment in Community-acquired Pneumococcal Pneumonia.
This completed clinical trial examined whether delaying antibiotic treatment affects outcomes in community-acquired pneumonia caused by Stre…
-
CLINICAL_TRIALS trial_result · 2014-04-23Clinical Trial Update: Community-Acquired Pneumonia - Study on the Initial Treatment With Antibiotics of Lower Respiratory Tract Infections [NA]
The record notes the completion of a clinical trial evaluating initial antibiotic treatment for community-acquired pneumonia, sponsored by U…
-
CLINICAL_TRIALS trial_result · 2014-03-24Clinical Trial Update: Use of Ceftaroline in Hospitalized Patients With Community Acquired Pneumonia [Phase 3]
This clinical trial update reports on a Phase 3 study of ceftaroline fosamil in hospitalized adults with community-acquired pneumonia.
-
CLINICAL_TRIALS trial_result · 2014-01-03Clinical Trial Update: Failure and Cardiovascular Events in Community-acquired Pneumonia
A completed clinical trial in community-acquired pneumonia reported treatment failure and cardiovascular events. The update highlights safet…
-
FDA approval · 2013-11-22FDA Approved: CEFIXIME — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for cefixime. This action updates the cefixime NDA, potentially expanding i…
-
CLINICAL_TRIALS trial_result · 2013-11-05Clinical Trial Update: Community-Acquired Pneumonia (CAP) Surveillance
Bayer-sponsored Community-acquired pneumonia (CAP) surveillance clinical trial has completed; no drug-specific data is included in this upda…
-
CLINICAL_TRIALS trial_result · 2013-10-16Clinical Trial Update: Standardized Emergency Care for Community Acquired Pneumonia (CAP)
The report notes completion of a clinical trial evaluating standardized emergency care for community-acquired pneumonia (CAP).
-
CLINICAL_TRIALS research · 2013-09-10Clinical Trial Update: A Phase III Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia [Phase 3]
This clinical trial update notes a Phase III study evaluating faropenem for adult community-acquired pneumonia. The current status is unknow…